Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Martin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Medicina (Kaunas, Lithuania)|October 17, 2020
Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?Naomi Martin, Xiaodie Tu, Alicia J Egan, et al.
Medicina (Kaunas, Lithuania)|September 25, 2020
Complement Properdin Regulates the Metabolo-Inflammatory Response to a High Fat DietRόisín C Thomas, Ramiar Kheder, Hasanain Alaridhee, et al.
Exercise Immunology Review|February 21, 2018
Microparticles and Exercise in Clinical PopulationsPatrick J Highton, Naomi Martin, Alice C Smith, et al.
BMC Pulmonary Medicine|December 3, 2003
Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impactI Christopher McManus, Hannah M Mitchison, Eddie M K Chung, et al.
Medicine and Science in Sports and Exercise|March 20, 2019
Microparticle Responses to Aerobic Exercise and Meal Consumption in Healthy MenPatrick J Highton, Fernanda R Goltz, Naomi Martin, et al.
Arthritis Research & Therapy|November 4, 2022
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trialMartin Bergman, Namita Tundia, Naomi Martin, et al.
Physiological Reports|October 9, 2018
Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory functionNaomi Martin, Alice C Smith, Maurice R Dungey, et al.
Frontiers in Physiology|August 15, 2017
The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney DiseaseEmma L Watson, Joao L Viana, David Wimbury, et al.
Arthritis Research & Therapy|June 24, 2022
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trialMartin Bergman, Namita Tundia, Naomi Martin, et al.
The New England Journal of Medicine|October 14, 2020
Trial of Upadacitinib or Abatacept in Rheumatoid ArthritisAndrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Medicina (Kaunas, Lithuania)|October 17, 2020
Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?Naomi Martin, Xiaodie Tu, Alicia J Egan, et al.
Medicina (Kaunas, Lithuania)|September 25, 2020
Complement Properdin Regulates the Metabolo-Inflammatory Response to a High Fat DietRόisín C Thomas, Ramiar Kheder, Hasanain Alaridhee, et al.
Exercise Immunology Review|February 21, 2018
Microparticles and Exercise in Clinical PopulationsPatrick J Highton, Naomi Martin, Alice C Smith, et al.
BMC Pulmonary Medicine|December 3, 2003
Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impactI Christopher McManus, Hannah M Mitchison, Eddie M K Chung, et al.
Medicine and Science in Sports and Exercise|March 20, 2019
Microparticle Responses to Aerobic Exercise and Meal Consumption in Healthy MenPatrick J Highton, Fernanda R Goltz, Naomi Martin, et al.
Arthritis Research & Therapy|November 4, 2022
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trialMartin Bergman, Namita Tundia, Naomi Martin, et al.
Physiological Reports|October 9, 2018
Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory functionNaomi Martin, Alice C Smith, Maurice R Dungey, et al.
Frontiers in Physiology|August 15, 2017
The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney DiseaseEmma L Watson, Joao L Viana, David Wimbury, et al.
Arthritis Research & Therapy|June 24, 2022
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trialMartin Bergman, Namita Tundia, Naomi Martin, et al.
The New England Journal of Medicine|October 14, 2020
Trial of Upadacitinib or Abatacept in Rheumatoid ArthritisAndrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, et al.
Pageof 3